Take a look at the Reveal Trailer for Raw Components Racing, a sci-fi racing game developed by the RCR Team. Players will enter a new world where the space race is taken literally, as pilots merge ...

To some, METR’s “time horizon plot” indicates that AI utopia—or apocalypse—is close at hand. The truth is more complicated. MIT Technology Review Explains: Let our writers untangle the complex, messy ...

Michael Rainey Jr and Joseph Sikora in the series finale of 'Power Book IV: Force' Power Book IV: Force Instagram SPOILER ALERT: The following reveals major plot points from the series finale of the ...

ICU Medical has issued a Class I recall for certain 150 mL IV Gravity Burette Sets after discovering some devices are missing an internal shut-off valve, increasing the risk of uncontrolled fluid flow ...

The AI infrastructure buildout is creating shortages of components including various types of chips. Prices of some components like advanced memory have surged. These pieces of hardware also are used ...

The adrenaline-pumping Season 3 of Starz's "Power Book IV: Force" continues ahead of the weekend. The crime drama, starring Joseph Sikora, follows his character Tommy Egan as he must "play offense and ...

"Power Book IV: Force" Season 3 just kicked off, and the action is already heating up. Tommy Egan (Joseph Sikora) remains one step ahead of his enemies in his journey to take over Chicago's drug scene ...

The booming IV hydration spa industry operates with virtually no oversight or data backing up its claims, according to the first comprehensive national analysis of hydration clinics. Subscribe to read ...

Rajiv Shesh is the Chief Revenue Officer at HCLSoftware where he leads revenue growth & customer advocacy for Products & Platforms division. What’s really powering AI? High-quality data—foundational ...

Forbes contributors publish independent expert analyses and insights. I track enterprise software application development & data management. Jul 03, 2025, 10:43am EDT Business 3d tablet virtual growth ...

When deciding whether to use subcutaneous (SubQ) or intravenous (IV) therapies, clinicians must weigh several clinical and practical factors. One of the first considerations is the type of cancer ...